Table of Contents

May 15, 2023; Volume 20,Issue 5

C

  1. Chai, Ruichao

    1. Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771

  2. Cui, Xiaoteng

    1. Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
    2. Expert opinion on translational research for advanced glioblastoma treatment
      Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang
      Cancer Biology & Medicine May 2023, 20 (5) 344-352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012

F

  1. Fang, Chuan

    1. Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061

H

  1. Hou, Pengyu

    1. Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061

J

  1. Jiang, Tao

    1. Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771

K

  1. Kang, Chunsheng

    1. Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
    2. Expert opinion on translational research for advanced glioblastoma treatment
      Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang
      Cancer Biology & Medicine May 2023, 20 (5) 344-352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012

L

  1. Li, Qiushi

    1. Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
      Chun Wang, Qiushi Li, Jian Xiao and Yang Liu
      Cancer Biology & Medicine May 2023, 20 (5) 325-343; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761

  2. Li, Ziru

    1. Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061

  3. Lin, Zihan

    1. Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771

  4. Liu, Xiaomin

    1. Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011

  5. Liu, Yang

    1. Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
      Chun Wang, Qiushi Li, Jian Xiao and Yang Liu
      Cancer Biology & Medicine May 2023, 20 (5) 325-343; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761

P

  1. Peng, Wenjie

    1. Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
      Yingyan Yu and Wenjie Peng
      Cancer Biology & Medicine May 2023, 20 (5) 369-384; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0046

T

  1. Tan, Yanli

    1. Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061

  2. Tong, Fei

    1. Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011

W

  1. Wang, Changsheng

    1. Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061

  2. Wang, Chun

    1. Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
      Chun Wang, Qiushi Li, Jian Xiao and Yang Liu
      Cancer Biology & Medicine May 2023, 20 (5) 325-343; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761

  3. Wang, Guangxiu

    1. Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011

  4. Wang, Qianghu

    1. Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771

  5. Wang, Qixue

    1. Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
    2. Expert opinion on translational research for advanced glioblastoma treatment
      Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang
      Cancer Biology & Medicine May 2023, 20 (5) 344-352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012

  6. Wang, Yunfei

    1. Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
    2. Expert opinion on translational research for advanced glioblastoma treatment
      Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang
      Cancer Biology & Medicine May 2023, 20 (5) 344-352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012

  7. Wu, Lingxiang

    1. Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771

  8. Wu, Rongrong

    1. Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771

X

  1. Xiao, Jian

    1. Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
      Chun Wang, Qiushi Li, Jian Xiao and Yang Liu
      Cancer Biology & Medicine May 2023, 20 (5) 325-343; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761

  2. Xu, Can

    1. Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061

Y

  1. Yao, Diru

    1. Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
      Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
      Cancer Biology & Medicine May 2023, 20 (5) 319-324; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771

  2. Yu, Yingyan

    1. Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
      Yingyan Yu and Wenjie Peng
      Cancer Biology & Medicine May 2023, 20 (5) 369-384; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0046

  3. Yuan, Xiaoye

    1. Development of glioblastoma organoids and their applications in personalized therapy
      Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang and Yanli Tan
      Cancer Biology & Medicine May 2023, 20 (5) 353-368; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0061

Z

  1. Zhao, Jixing

    1. Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011

  2. Zhou, Junhu

    1. Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
      Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu and Qixue Wang
      Cancer Biology & Medicine May 2023, 20 (5) 385-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0011
    2. Expert opinion on translational research for advanced glioblastoma treatment
      Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang and Chunsheng Kang
      Cancer Biology & Medicine May 2023, 20 (5) 344-352; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0012
Back to top

In this issue

Cancer Biology & Medicine: 20 (5)
Cancer Biology & Medicine
Vol. 20, Issue 5
15 May 2023

Submit

Sign up for alerts